Zen Technologies' ₹135 Crore Cogknit Acquisition, Explained

Quick answer: Zen Technologies, a listed Hyderabad defence company, will pay up to ₹135.15 crore in cash for 51.98% of Cogknit Semantics, a Bengaluru battlefield-software startup. That values Cogknit at about ₹260 crore against ₹48 lakh of FY26 revenue, roughly 540x. Zen is buying a product that has been through Indian Army trials, not revenue.

Zen Technologies, known for training simulators and anti-drone systems, has agreed to pay up to ₹135.15 crore in cash for 51.98% of Cogknit Semantics, a Bengaluru startup that builds battlefield management software for the Indian Army. The price values Cogknit at about ₹260 crore. Cogknit's revenue last year was ₹48 lakh. That gap is the story. Zen is not buying revenue. It is buying a product that has been through Army field trials, and the five years it took to get there.

The Snapshot

The One-Line

Zen is paying about 540 times last year's revenue for control of a startup whose battlefield software has already been through Indian Army trials, betting that its own customer access and balance sheet can turn a tested product into orders faster than it could build one.

What Happened

The timeline

• 17 October 2026: Zen's board approves the deal. The share purchase agreement, share subscription agreement and shareholders' agreement are signed the same day.
• 18 October 2026: Zen announces the deal in a press release to NSE and BSE.
• By 13 December 2026: Completion is due, subject to conditions precedent. No government or regulatory approval is needed, and it is not a related-party transaction.

Who Cogknit is

• Incorporated in Bengaluru in 2009. Founder and CEO Anuroop Iyengar.
• Started with signals data processing and edge AI for infantry.
• Built a Battlefield Management System (BMS) for main battle tanks through iDEX, the defence ministry's innovation challenge. The system links tanks, vehicles and soldiers into one real-time picture of the battlefield.
• Completed field trials with the Indian Army and won the Raksha Mantri's Award for Innovation in 2022.
• Revenue has fallen two years in a row: ₹2.24 crore in FY24, ₹0.78 crore in FY25 and ₹0.48 crore in FY26.

What Zen is buying

• A tested command-and-control product. Zen's chairman, Ashok Atluri, said Cogknit's path from iDEX selection to field trials took "nearly five years" of Army feedback. That is the time Zen would otherwise have to spend.
• A layer that sits on top of what Zen already sells. Zen positions the BMS alongside its training simulators, counter-drone systems, drones and its proposed AI platform, Samvid.
• The team. Cogknit's founding team stays on to run the company.

The Numbers

Deal terms

Cogknit's revenue

Zen, the buyer (consolidated)

What we can infer

• About 540x revenue. ₹260 crore against ₹48 lakh of FY26 revenue. Revenue is not what is being priced.
• About a tenth of Zen's cash. ₹135.15 crore is roughly 10% of the ₹1,308 crore Zen held in March. Zen can afford to be wrong on this one.
• Bought while its own revenue fell. Zen's revenue dropped about 29% in FY26. Adding products that sit on top of its existing range is one way to win bigger orders from the same customer.

The Structure

A majority stake bought partly from an existing shareholder and partly by putting new money into the company, with control written into the shareholders' agreement.

• Primary plus secondary. Part of the money buys shares from an existing shareholder, who gets cash out. Part goes into Cogknit through new preference shares, which funds the company. The split is not disclosed, so we cannot say how much stays in the business.
• Control through the shareholders' agreement, not just the 51.98%. Zen can nominate a majority of the board and has affirmative voting rights on key decisions under the shareholders' agreement.
• Founders stay. The founding team keeps running the company. In a business whose value is its know-how, that matters as much as the headline percentage.
• A co-investor in the round. Ashish Kacholia and associates are investing alongside Zen in the primary round.
• Convertible preference shares. The Series A CCCPS convert into equity shares later. The 51.98% is on a fully diluted basis, so it already counts them as converted.

Which risk did each side take?

• Zen pays a capability price for a company with almost no revenue. Its bet only pays off if the BMS turns into Army orders, and defence procurement is slow.
• The selling shareholder gets cash now. Cogknit gets a well-funded parent and fresh capital from the primary round.
• What neither side has resolved: when, or whether, the BMS becomes a contracted Army programme. Nothing disclosed so far shows an order.

Why It Matters

1. In defence tech, a field-trialled product is worth more than revenue. Defence buyers move slowly and test for years. A product that has already been through Army trials cannot be replicated quickly, which is why a profitable buyer like Zen will pay hundreds of times revenue for one.

2. Zen is using its cash to buy capability. It ended FY26 with ₹1,308 crore of cash and no debt. Buying a tested product is faster than building one, and a cash-rich buyer can absorb the risk of paying early.

3. Primary-plus-secondary is a way to buy control without stripping the target. The seller gets liquidity, the company gets funding, and the buyer gets a majority. For a startup that still needs to grow, that is a cleaner way in than a pure buyout.

The Buyer's Takeaway

Written for anyone buying a stake in a small Indian company, not a listed defence group:

• Only pay for capability if you can turn it into revenue. Zen can price Cogknit on its product because it already sells to the same customer. If you do not bring the customers, distribution or orders, pay for the revenue that exists.
• Control lives in the shareholders' agreement. Majority board seats and affirmative votes matter as much as owning more than 50%. When you buy a majority stake, negotiate these rights line by line.
• Mix primary and secondary when the business still needs cash. Paying the seller only, when the company needs money to grow, leaves you funding it again later.
• Keep the founders when the know-how is the asset. Leave them with a stake and a role. In a product business, the people are a large part of what you paid for.
• Size the bet against your balance sheet. Zen is spending about a tenth of its cash. A small buyer paying for potential should cap the amount at what it could lose without hurting the core business.

For how large strategic buyers structure deals, see our explainers on Coforge's Encora acquisition and upGrad's Unacademy deal.

The Kautilya Deal Score

Our view, not a rating from any third party.

Verdict: a capability bet. Strategic fit is the strongest axis: the BMS sits directly on top of what Zen already sells to the same customer. The structure is good, with board control, the founding team retained and fresh money going into the company. Price discipline and cash-flow quality are weak by any revenue measure, with Cogknit's revenue falling two years in a row to ₹48 lakh. The deal only makes sense if the product becomes orders, and Zen is sized to absorb the loss if it does not.

The Operator's Take

If you only look at the multiple, this deal looks absurd. 540 times revenue. But Zen is not buying a revenue line. It is buying five years of Army testing it does not have to repeat. What I would want to see next is a contracted order for the BMS, or a clear line from Zen on when one is expected. Until then, this is a well-structured option on a product, paid for with money Zen can afford to lose. For a small buyer, the lesson is the structure, not the price.

Dev Shah

Sources & Method

Sources, by confidence

• High: Deal size, stake, primary and secondary structure, co-investor, Cogknit's business, iDEX history, Army field trials, 2022 award, founder, quotes: Zen Technologies press release to NSE and BSE, 18 October 2026.
• High: Cogknit's incorporation in 2009, revenue for FY24 to FY26, CCCPS price, completion date, board rights, no related party, no regulatory approvals: Zen's Regulation 30 disclosure of 17 October 2026, as reported by Business Upturn and The Next Read, which agree on every figure.
• High: Zen FY25 and FY26 revenue, profit, cash and March 2026 order book: Zen FY26 results, as reported by Multibagg.
• Kautilya calculations (not disclosed figures): implied value of about ₹260 crore; about 540x FY26 revenue; deal at about 10% of Zen's cash; Zen's revenue fall of about 29%.

Open items we could not verify

• How the ₹135.15 crore splits between the secondary purchase and the primary round.
• How much Ashish Kacholia and associates are investing.
• The conversion terms of the Series A CCCPS.
• Whether Zen has an option or obligation to buy the remaining stake.
• Any Army order for the BMS.

If you are evaluating a stake in a small Indian company yourself, our guide on how to value a small business in India covers how to price a business when revenue does not tell the whole story.

Disclaimer: This explainer is based on Zen Technologies' stock exchange disclosures and published coverage of them. It is analysis, not investment or legal advice. Check current figures before relying on them.